P3 Health Partners Stock Performance
| PIIIW Stock | USD 0.01 0.00 0.000002% |
On a scale of 0 to 100, P3 Health holds a performance score of 5. The firm owns a Beta (Systematic Risk) of 1.28, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, P3 Health will likely underperform. Please check P3 Health's information ratio, as well as the relationship between the value at risk and kurtosis , to make a quick decision on whether P3 Health's current price history will revert.
Risk-Adjusted Performance
Mild
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in P3 Health Partners are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent forward indicators, P3 Health showed solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | Earnings call transcript P3 Health Partners Q1 2025 revenue falls short - Investing.com UK | 05/15/2025 |
2 | P3 Health Partners price target lowered to 8 from 12.50 at TD Cowen - Yahoo Finance | 05/29/2025 |
3 | Wolf Haldenstein Adler Freeman Herz LLP is investigating P3 Health Partners, Inc. - GlobeNewswire | 06/16/2025 |
4 | Acquisition by Chicago Pacific Founders Ugp Iii, Llc of 90000 shares of P3 Health at 3.4958 subject to Rule 16b-3 | 07/10/2025 |
5 | What drives P3 Health Partners Inc. stock price - Tremendous financial leverage - Jammu Links News | 07/18/2025 |
6 | P3 Health Partners Inc. Equity Warrant Stock Analysis and Forecast - Breakout portfolio performance - Autocar Professional | 07/21/2025 |
7 | Healthcare Provider P3 Health Partners Sets Q2 2025 Earnings Release Date - Conference Call Details Inside - Stock Titan | 07/31/2025 |
| Begin Period Cash Flow | 40.9 M | |
| Total Cashflows From Investing Activities | 14.5 M | |
| Free Cash Flow | -110.1 M |
P3 Health Relative Risk vs. Return Landscape
If you would invest 0.88 in P3 Health Partners on May 8, 2025 and sell it today you would earn a total of 0.12 from holding P3 Health Partners or generate 13.64% return on investment over 90 days. P3 Health Partners is currently producing 0.6899% returns and takes up 9.9156% volatility of returns over 90 trading days. Put another way, 88% of traded stocks are less volatile than PIIIW, and 87% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
P3 Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for P3 Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as P3 Health Partners, and traders can use it to determine the average amount a P3 Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0696
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PIIIW | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 9.92 actual daily | 88 88% of assets are less volatile |
Expected Return
| 0.69 actual daily | 13 87% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average P3 Health is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of P3 Health by adding it to a well-diversified portfolio.
P3 Health Fundamentals Growth
PIIIW Stock prices reflect investors' perceptions of the future prospects and financial health of P3 Health, and P3 Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on PIIIW Stock performance.
| Return On Equity | -1.2 | ||||
| Return On Asset | -0.24 | ||||
| Profit Margin | (0.09) % | ||||
| Operating Margin | (0.10) % | ||||
| Revenue | 1.5 B | ||||
| Gross Profit | (64.17 M) | ||||
| EBITDA | (197.76 M) | ||||
| Net Income | (310.38 M) | ||||
| Cash And Equivalents | 4.34 M | ||||
| Cash Per Share | 0.10 X | ||||
| Total Debt | 166.16 M | ||||
| Current Ratio | 0.45 X | ||||
| Book Value Per Share | 19.38 X | ||||
| Cash Flow From Operations | (110.13 M) | ||||
| Earnings Per Share | (1.34) X | ||||
| Total Asset | 783.42 M | ||||
| Retained Earnings | (503.19 M) | ||||
| Working Capital | (312.27 M) | ||||
About P3 Health Performance
Evaluating P3 Health's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if P3 Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if P3 Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 0.34 | 0.35 | |
| Return On Tangible Assets | (0.65) | (0.68) | |
| Return On Capital Employed | (1.09) | (1.14) | |
| Return On Assets | (0.17) | (0.18) | |
| Return On Equity | (1.79) | (1.88) |
Things to note about P3 Health Partners performance evaluation
Checking the ongoing alerts about P3 Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for P3 Health Partners help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| P3 Health Partners is way too risky over 90 days horizon | |
| P3 Health Partners has some characteristics of a very speculative penny stock | |
| P3 Health Partners appears to be risky and price may revert if volatility continues | |
| P3 Health Partners has high likelihood to experience some financial distress in the next 2 years | |
| P3 Health Partners has accumulated 166.16 M in total debt. P3 Health Partners has a current ratio of 0.44, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about P3 Health's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the revenue of 1.5 B. Net Loss for the year was (310.38 M) with loss before overhead, payroll, taxes, and interest of (64.17 M). | |
| P3 Health Partners has accumulated about 4.34 M in cash with (110.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.1, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| P3 Health Partners has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Healthcare Provider P3 Health Partners Sets Q2 2025 Earnings Release Date - Conference Call Details Inside - Stock Titan |
- Analyzing P3 Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether P3 Health's stock is overvalued or undervalued compared to its peers.
- Examining P3 Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating P3 Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of P3 Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of P3 Health's stock. These opinions can provide insight into P3 Health's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for PIIIW Stock Analysis
When running P3 Health's price analysis, check to measure P3 Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy P3 Health is operating at the current time. Most of P3 Health's value examination focuses on studying past and present price action to predict the probability of P3 Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move P3 Health's price. Additionally, you may evaluate how the addition of P3 Health to your portfolios can decrease your overall portfolio volatility.